Victrex Appoints Investec as Joint Corporate Broker
The specialty chemicals company has appointed Investec Bank plc as a Joint Corporate Broker, working alongside the existing broker J.P. Morgan Securities plc.
The specialty chemicals company has appointed Investec Bank plc as a Joint Corporate Broker, working alongside the existing broker J.P. Morgan Securities plc.
The specialty chemicals company has announced a change in shareholding, with Norges Bank increasing its stake to 8.81%.
The specialty chemicals company has announced a change in shareholding, with Norges Bank increasing its stake to 7.43%.
The specialty chemicals company has announced a change in shareholding, with FIL Limited increasing its stake to 9.766%.
The specialty chemicals company announces a non-executive director has purchased shares in the business.
The specialty chemicals manufacturer reported mixed H1 results, with revenue up 5% but profits down 17%. Facing headwinds from FX, China operations, and Medical segment weakness, the outlook remains cautious.
The specialty chemicals company has secured a major contract award that supports the development and commercialization of its 'Magma' programme, representing a significant growth opportunity.
The prominent specialty chemicals company announces a non-executive director has purchased additional shares.
The specialty chemicals company reports a solid start to the year, with Q1 revenue and volume growth, but trading conditions remain mixed, particularly in the Medical segment.
Regulatory update on shareholding changes for this specialty chemicals company.